Mechanism of Wnt activation after KRAS inhibition
Funding period: 2021-2029
Project Leaders
Abstract
The Wnt and Ras pathways are intricately connected in colorectal cancer, thereby supporting carcinogenesis and late-stage cancer phenotypes. We showed that MEK1/2 inhibition stimulates Wnt signaling in colorectal cancer models and uncovered AXIN1 loss by combined transcriptional and translational repression as a potential underlying mechanism. Here, we will extend our focus to pan-KRAS inhibition-mediated stimulation of Wnt signaling, and aim to identify common and differential mechanisms of activation in comparison to MEK1/2 inhibitors.
Project-related Publications
Combined MEK and PARP inhibition enhances radiation response in rectal cancer
Digestive cancers: mechanisms, therapeutics and management
The Roles of Secreted Wnt Ligands in Cancer
Int J Mol Sci. 2023 Mar 10;24(6):5349. doi: 10.3390/ijms24065349. PMID: 36982422
Learn moreCross-Talk between p53 and Wnt Signaling in Cancer
Biomolecules. 2022 Mar 15;12(3):453. doi: 10.3390/biom12030453. PMID: 35327645
Learn moreMulti-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
Nat Commun. 2019 May 16;10(1):2197. doi: 10.1038/s41467-019-09898-0. PMID: 31097693
Learn moreCRISPR/Cas9 for cancer research and therapy
Semin Cancer Biol. 2019 Apr;55:106-119. doi: 10.1016/j.semcancer.2018.04.001. Epub 2018 Apr 16. PMID: 29673923
Learn moreWnt signaling in cancer
Oncogene. 2017 Mar;36(11):1461-1473. doi: 10.1038/onc.2016.304. Epub 2016 Sep 12. PMID: 27617575
Learn moreCRISPRlibrary designer (CLD): software for multispecies design of single guide RNA libraries.
Genome Biol. 2016 Mar 24;17:55. doi: 10.1186/s13059-016-0915-2. PMID: 27013184
Learn more